Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer

Cancer

Volumn 89, Issue 1, 2000, Pages 123-134

  Bostwick, David G ^a,b   Alexander, Erik E ^c   Singh, Rohini ^c   Shan, Ailin ^c   Qian, Junqi ^a   Santella, Regina M ^d   Oberley, Larry W ^e   Yan, Tao ^e   Zhong, Weixiong ^e   Jiang, Xiaohong ^e   Oberley, Terry D ^f  

^a BOSTWICK LABORATORIES   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c DEPARTMENT OF UROLOGY   (United States)

^d Department of Orthopaedic Surgery   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Antioxidant enzymes; Catalase; Prostate carcinoma; Prostatic intraepithelial neoplasia; Prostatic neoplasms; Reactive oxygen species; Superoxide dismutase

Indexed keywords

CATALASE; MANGANESE SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

AMINO ACID SEQUENCE; ARTICLE; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

AGED; ANTIOXIDANTS; CATALASE; DNA DAMAGE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE;

EID: 0034234580     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9     Document Type: Article

References (53)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1999;49:8-31.
2. Sakr WA, Grignon DJ, Haas GP, Heilbrun LK, Pontes JE, Crissman JD. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol 1996;30:138-44.
3. Billis A: Age and race distribution of high-grade prostatic intraepithelial neoplasia: an autopsy study in Brazil (South America). J Urol Pathol 1996;5:1-7.
4. Baker AM, Oberley LW, Cohen MB. Expression of antioxidant enzymes in prostatic adenocarcinoma. Prostate 1997; 32:229-33.
5. Tunn S, Nass R, Ekkernkamp A, Schulze H, Krieg M. Evaluation of average life span of epithelial and stromal cells of human prostate by superoxide dismutase activity. Prostate 1989;15:263-71.
6. Olinski R, Zastawny T, Foksinski M, Barecki A, Dizdaroglu M. DNA base modifications and antioxidant enzyme activities in human benign prostatic hyperplasia. Free Radic Biol Med 1995;18:807-13.
7. Bostwick DG. Neoplasms of the prostate. In: Bostwick DG, Eble JN, editors. Urologic surgical pathology. 1st edition. St. Louis: Mosby, 1997:343-422.
8. Bostwick DG, Shan A, Qian J, Darson M, Maihle NJ, Jenkins RB, et al. Independent origin of multiple foci of prostatic intraepithelial neoplasia (PIN): comparison with matched foci of prostate cancer. Cancer 1998;83:1995-2002.
9. Yarborough A, Zhang Y, Hsu T, Santella R. Immunoperoxidase detection of 8-hydroxydeoxyguanisine in Aflatoxin B1-treated rat liver and human oral mucosal cells. Cancer Res 1996;56:683-8.
10. Spitz D, Oberely L. An assay for superoxide dismutase activity in mammalian tissue homogenates. J Anal Biochem 1989;179:8-18.
11. Lowry G, Rosebrough N, Farr A, Randall R. J Biol Chem 1951;193:265-75.
12. Beers RF Jr., Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1952;195:133-40.
13. Ripple MO, Henry WF, Rago RP, Wilding G. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst 1997;89:40-8.
14. Wilding G. Endocrine control of prostate cancer. Cancer Surv 1995;23:43-62.
15. Thompson IM, Coltman CA, Brawley OW, Ryan A. Chemo-prevention of prostate cancer. Semin Urol 1995;13:122-9.
16. Amstad P, Peskin A, Mirault ME, Moret R, Zbinden I, Cerutti P. The balance between CuZn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stree. Biochemistry 1991;30:9305-13.
17. Sun Y, Oberley LW. Redox regulation of transcriptional activators. Free Radic Biol Med 1996;21:335-48.
18. Li N, Oberley TD, Oberley LW, Zhong W. Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells has multiple effects on cell phenotype. Prostate 1998;35:221-33.
19. Muse KE, Oberley TD, Sempf JM, Oberley LW. Immunolocalization of antioxidant enzymes in adult hamster kidney. Histochem J 1994;26:734-53.
20. Bostwick DG, Pacelli A, Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate 1996;29:117-34.
21. Sakr WA, Macoska JA, Benson PD, Grignon DJ, Wolman SR, Pontes JE, et al. Allelic loss in metastatic, multisampled prostate cancer. Cancer Res 1994;54:3273-9.
22. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM. Chromosomal anomlies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995;55:5408-14.
23. Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, et al. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res 1996;56: 4475-82.
24. Hethcote HW, Knudson AG Jr. Model for the incidence of embryonal cancers: application to retinoblastoma. Proc Natl Acad Sci USA 1978;75:2453-7.
25. Oberley LW, Oberley TD. Oxyradicals and malignant transformation. In: McCord J, editor. Oxyradicals in medical biology. JAI Press, Inc. In press.
26. Yu L, Gengaro P, Burke TJ, Schrier RW. Reactive oxygen species (ROS) are involved in rat tubular hypoxia-reoxygeneration (H/R) injury. Kidney Int 1994;46:1747-53.
27. Warner HR. Superoxide dismutase, aging, and degenerative disease. Free Radic Biol Med 1994;17:249-58.
28. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996;273:59-63.
29. He P, Yasumoto K. Dietary butylated hydroxytoluene counteracts with paraquat to reduce the rate of hepatic DNA single strand breaks in senescence-accelerated mice. Mech Ageing Devel 1994;76:43-8.
30. Draper HH, Agarwal S, Nelson DE, Wee JJ, Ghoshal AK, Farber E. Effects of peroxidative stress and age on the concentration of a deoxyguanosine-malondialdehyde adduct in rat DNA. Lipids 1995;30:959-61.
31. Stadtman ER. Protein oxidation and aging. Science 1992;257: 1220-4.
32. Leadon SA. Production and repair of DNA damage in mammalian cells. Health Phys 1990;59:15-22.
33. Mo JQ, Hom DG, Andersen JK. Decreases in protective enzymes correlates with increased oxidative damage in the aging mouse brain. Mechan Ageing Devel 1995;81:73-82.
34. Ames BA, Shingenaga MK, Park E-M. Oxidation damage and repair: chemical, biological and medical aspects. Davies KJA, editor. Elmsford, NY: Pergamon, 1991:181-7.
35. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988;12:897-906.
36. Qian J, Wollan P, Bostwick DG. The extent and multicentricity of high grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum Pathol 1997;28:143-8.
37. Aihara M, Wheeler TM, Ohori M, Scardino PT. Heterogeneity of prostate cancer in radical prostatectomy specimens. Urology 1994;43:60-6.
38. Cheng L, Song S-Y, Pretlow TG, Abdul-Karin FW, Kung H-J, Dawson DV, et al. Evidence of independent origin of multiple tumors from patients with prostate cancer. J Natl Cancer Inst 1998;90:233-7.
39. Jenkins RB, Qian J, Lieber MM, Bostwick DG. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 1997;57:524-31.
40. Konishi N, Hiasa Y, Matsuda H, Tao M, Tsuzuki T, Hayashi I, et al. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. Am J Pathol 1995;147:1112-22.
41. Greene DR, Rogers E, Wessels EC, Wheeler TM, Taylor SR, Santucci RA, et al. Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features. J Urol 1994;151:1301-7.
42. Stoler DL, Chen N, Basik M, Kahlenberg MS, Rodriguez-Bigas MA, Petrelli NJ, et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci U S A 1999;96:15121-6.
43. Murray GI, Taylor VE, McKay JA, Weaver RJ, Ewen SWB, Melvin WT, et al. The immunohistochemical localization of drug-metabolizing enzymes in prostate cancer. J Pathol 1995;177:147-52.
44. Moskaluk CA, Duray PH, Cowan HK, Linehan M, Merino M. Immunohistochemical expression of π-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate. Cancer 1997;79:1595-9.
45. Cookson MS, Reuter VE, Linkov I, Fair WR. Glutathione S-transferase Pi (GST-π) class expression by immunohistochemistry in benign and malignant prostate tissue. J Urol 1997;157:673-6.
46. Pacelli A, Cheng L, Bergstralh EJ, Slezak JM, Shanks J, Bostwick DG. Glutathione S-transferase Pi class expression in benign prostatic epithelium, primary prostate cancer, and lymph node metastases: correlation with systemic progression and patient survival. Cancer 2000.
47. Lee W-H, Morton RA, Epstein JL, Brooks JD, Campbell PA, Bova GS, et al. Cytidine methylation of regulatory sequences near the Pi- class glutathione S-transferase gene accompanies human prostate carcinogenesis. Proc Natl Acad Sci U S A 1994;91:11733-7.
48. Lee WH, Isaacs WB, Bova GS, Nelson WG. CG island methylation changes near GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev 1997;6:443-50.
49. Hoekstra WG. Biochemical function of selenium and its relation to vitamin E. Fed Proc 1975;34:2083-9.
50. Yoshizawa K, Willett WC, Morris SJ, Stampfer MJ, Spiegelman D, Rimm EB, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-24.
51. Clark LC, Combs GF Jr., Turnbull BW, Slate EH, Chalker DK, Chow J, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996;276:1957-63.
52. The alpha-tocopherol, beta carotene cancer prevention study group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35.
53. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998;90: 440-6.